OPTOVUE LTDActive

Company number 10090302Private limited companyIncorporated 2016

Key figures

£567,354+6.4%
Net assets 2025/26
+4.7%
Average annual growth 2020/21–2025/26
0200 k400 k600 k2020/212021/222022/232023/242024/252025/26

Like most small UK companies, OPTOVUE LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0250 k500 k750 k2020/212021/222022/232023/242024/252025/26
Filed accounts2020/21–2025/26
2021/222022/232023/242024/252025/26
Cash at bank and in hand376,883244,560170,340107,052154,935
Total assets588,640661,220679,411562,744592,672
Total liabilities74,53955,28499,35918,23416,389
Net assets / total equity513,166588,052565,807533,270567,354
Average number of employees22222

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2026

86900

As described in the company's latest filed accounts.

Summary: OPTOVUE LTD

Company

OPTOVUE LTD is a private limited company registered with Companies House under company number 10090302. It was incorporated on 30 Mar 2016. Its status is active. The registered office is in Maidstone (ME14). Its nature of business (SIC 2007) is other human health activities (86900).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 Mar 2026); the company files small company accounts (filleted). Net assets were £567,354, up 6.4% on the previous year. Cash at bank and in hand was £154,935. Total assets were £592,672 and total liabilities £16,389. The company had an average of 2 employees. Figures are available for 6 financial years (2020/21–2025/26).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 12 Apr 2027.